Can I read IDDF2020-ABS-0147 Development of a validated nomogram to predict aggressive Crohn’s disease: a retrospective cohort study on EtoBox?

IDDF2020-ABS-0147 Development of a validated nomogram to predict aggressive Crohn’s disease: a retrospective cohort study by Yao, Jiayin ;Zhao, Junzhang ;Hu, Bang ;Zhi, Min is a scholarly article available to read on EtoBox.

What is IDDF2020-ABS-0147 Development of a validated nomogram to predict aggressive Crohn’s disease: a retrospective cohort study about?

## Methods We randomised consecutive patients diagnosed with ASUC ( modified Truelove and Witt's classification) to receive placebo infusions or combination antibiotics (intravenous ceftriaxone and metronidazole) groups. Response as defined by oxford criteria was used to assess response on day three. We also assessed changes in partial Mayo score, CRP levels and reduction in fecal calprotectin at day three. Also, we assessed the need for second line drug therapy, colectomy, length of hospital stay and mortality by day 28. Results Fifty patients were randomised: 25 in each arm (Median age: 33, IQR 25-45, 23(46%) males). Twenty-two patients had extensive disease, while the median disease duration was 24 months. Sixteen patients (64%)in antibiotic arm responded (complete and partial response) at day three while 18 (72%) in the placebo arm responded. Three patients from the antibiotic group underwent colectomy. Three patients in the antibiotic arm received intravenous cyclosporine, whereas four patients in the placebo group received cyclosporine (p=0.725). There was no significant difference in change in CRP, Partial Mayo and fecal calprotectin between the two groups on day three. Conc

Author

Yao, Jiayin ;Zhao, Junzhang ;Hu, Bang ;Zhi, Min

Publisher

BMJ Publishing Group Ltd and British Society of Gastroenterology

Published

2020

Language

CA